Page Banner

United States Department of Agriculture

Agricultural Research Service


Location: Children's Nutrition Research Center

Title: IOM committee members respond to Endocrine Society vitamin D guideline

item Rosen, Clifford
item Abrams, Steven
item Aloia, John
item Brannon, Patsy
item Clinton, Steven
item Durazo-arvizu, Ramon
item Gallagher, J
item Gallo, Richard
item Jones, Glenville
item Kovacs, Christopher
item Manson, Joann
item Mayne, Susan
item Ross, A
item Shapses, Sue
item Taylor, Christine

Submitted to: Journal of Clinical Endocrinology and Metabolism
Publication Type: Review Article
Publication Acceptance Date: 2/10/2012
Publication Date: 4/1/2012
Citation: Rosen, C.J., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., Durazo-Arvizu, R.A., Gallagher, J.C., Gallo, R.L., Jones, G., Kovacs, C.S., Manson, J.E., Mayne, S.T., Ross, A.C., Shapses, S.A., Taylor, C.L. 2012. IOM committee members respond to Endocrine Society vitamin D guideline. Journal of Clinical Endocrinology and Metabolism. 97(4):1146-1152.

Interpretive Summary:

Technical Abstract: In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population.

Last Modified: 08/16/2017
Footer Content Back to Top of Page